Medical News

RSS

Introduction of the Endocrine Disruption Prevention Act of 2009 commended

The Endocrine Society commends Representative Jim Moran (D-VA) and Senator John Kerry (D-MA) for introducing the Endocrine Disruption Prevention Act of 2009 (H.R. 4190; S. 2828). The bill, endorsed by the Society, amends the Public Health Service Act by authorizing the National Institute of Environmental Health Sciences to conduct a research program on endocrine disruption aimed at preventing and reducing the production of and the public's exposure to harmful chemicals.

5 Dec 2009

STERIS acts in response to FDA's recent notice on SYSTEM 1 Sterile Processing System

STERIS Corporation was notified on December 3, 2009 that the U.S. Food and Drug Administration (FDA) had issued a notice to healthcare facility administrators regarding the regulatory status of the STERIS SYSTEM 1® Sterile Processing System, as well as actions healthcare facilities should take if they use this device.

5 Dec 2009

Vertex Pharmaceuticals reports underwriters purchase additional stock at 38.50 per share

Vertex Pharmaceuticals Incorporated today announced that the underwriters of its public offering have exercised in full their option to purchase an additional 1,500,000 shares of common stock at the public offering price of $38.50 per share.

5 Dec 2009

97 new drugs and vaccines in development for HIV/AIDS treatment, finds report

Chemistry World recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) that identifies 97 new drugs and vaccines in development for HIV/AIDS and related conditions.

5 Dec 2009

New data reveals insurance-based discrimination is more common among lower income women

According to an analysis of statewide data taken from 1998-2001, women in Oregon who made less than $50,000 a year were more than three times likely to report they were discriminated against by health providers because of their insurance status during pregnancy and delivery

5 Dec 2009

PharmAthene's Valortim demonstrates potential for anthrax treatment

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is presenting results of a study demonstrating the effectiveness of Valortim® in an inhalation anthrax model in the New Zealand White (NZW) rabbit.

5 Dec 2009

Prospect Medical Holdings completes registered exchange offer

Prospect Medical Holdings, Inc., today announced the completion of its exchange offer (the "Exchange Offer") for any and all of its outstanding 123/4% Senior Secured Notes, Series A, due 2014, which are not registered under the Securities Act of 1933 (the "Private Notes"), for an equal principal amount of its 123/4% Senior Secured Notes, Series B, due 2014, which have been registered under the Securities Act of 1933.

5 Dec 2009

Health experts available to discuss national healthcare policy issues

Experts at the Keck School of Medicine of the University of Southern California and the USC School of Pharmacy are available to discuss critical national healthcare and healthcare policy issues.

5 Dec 2009

Critical enzyme activity provides new insight into heart disease mechanisms

Using a new mathematical model of heart cells, University of Iowa investigators have shown how activation of a critical enzyme, calmodulin kinase II (CaM kinase), disrupts the electrical activity of heart cells.

5 Dec 2009

Unique project to address key healthcare reform issue to be launched

Groundbreaking ceremonies on December 15 will mark the launch of a unique project that exemplifies how new technologies are being used to address a key healthcare reform issue: the multi-billion dollar cost of repeatedly hospitalizing patients with chronic conditions such as diabetes, high blood pressure, heart failure, asthma and lung disease.

5 Dec 2009

Biotechnology Consulting Poland applies to the EU for structural and cohesion funding

In the same way that the European Union has previously made major infrastructure investments in countries such as Ireland, the EU is now encouraging and funding the development of high tech companies in Poland through its Structural and Cohesion Funds.

5 Dec 2009

Red Cross workers educate public on unfair labor conditions

Teamster members employed by the Philadelphia chapter of the American Red Cross are hard at work educating the public about the unfair labor conditions that they endure that could potentially put Philadelphia's blood supply at risk. More than 100 employees went on strike and set up a picket line yesterday when their issues were ignored by their employer.

5 Dec 2009

RetireSafe calls for the Senate to oppose the Dorgan Importation plan

Today, the senior advocacy group RetireSafe urged the Senate to defeat the Dorgan Importation plan encompassed in SA 2793. RetireSafe President Thair Phillips said, "Senator Dorgan's importation amendment is poised to open our borders, allowing our safe, closed drug system to be breached, and our health to be endangered. We could soon be getting drugs that were stored in tin containers and car trunks. This could literally be a 'killer' amendment, it puts all Americans and especially seniors at risk, and it should be soundly defeated."

5 Dec 2009

Findings underscore the need for additional medical student education for healthcare reform

As the population of people with chronic conditions and health care costs rise, so do opportunities for implementing health prevention strategies. Jan Carney, M.D., M.P.H., associate dean for public health at the University of Vermont (UVM) College of Medicine, believes a critical strategy for reforming the health care system lies in teaching medical students about prevention and public health.

5 Dec 2009

Oxygen Biotherapeutics commences enrollment in clinical trial of Oxycyte emulsion for TBI

Oxygen Biotherapeutics, Inc. today announced that the first patient has been enrolled in the company's Phase II-b, dose escalation, clinical trial in Switzerland for use of Oxycyte(TM) emulsion in traumatic brain injury (TBI). Oxycyte is the Company's perfluorocarbon (PFC) therapeutic oxygen carrier.

5 Dec 2009

Biomagnetics Diagnostics discusses utilization of acquired Los Alamos National Security intellectual property

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection provides the following recap of yesterday's investor conference call, which discussed the Company’s acquisition of intellectual property rights from Los Alamos National Security.

5 Dec 2009

Study on fruit flies may help in understanding the root cause of stem cell diseases

The body is a battle zone. Cells constantly compete with one another for space and dominance. Though the manner in which some cells win this competition is well known to be the survival of the fittest, how stem cells duke it out for space and survival is not as clear.

5 Dec 2009

Recession continues to impact low-income families with disabled children

The prolonged recession is deepening the financial burden for some of the country's most vulnerable families, a new study indicates.

5 Dec 2009

Florida's top nonprofits receive awards for improving health care

Today, seven of Florida's top nonprofits received awards for their work in improving the health of Florida's uninsured and underserved at The Blue Foundation for a Healthy Florida's 2009 Sapphire Award ceremony.

5 Dec 2009

Appropriate toys for children: Suggestions from doctors and experts

With the excitement of the holidays, parents and relatives eagerly purchase the hottest toys and latest items for their children. But it's during the hustle and bustle of the season that many fail to buy age appropriate gifts and they tend to disregard warnings on these toys and gifts when it comes to ensuring safety.

5 Dec 2009

Medical News

Introduction of the Endocrine Disruption Prevention Act of 2009 commended

STERIS acts in response to FDA's recent notice on SYSTEM 1 Sterile Processing System

Vertex Pharmaceuticals reports underwriters purchase additional stock at 38.50 per share

97 new drugs and vaccines in development for HIV/AIDS treatment, finds report

New data reveals insurance-based discrimination is more common among lower income women

PharmAthene's Valortim demonstrates potential for anthrax treatment

Prospect Medical Holdings completes registered exchange offer

Health experts available to discuss national healthcare policy issues

Critical enzyme activity provides new insight into heart disease mechanisms

Unique project to address key healthcare reform issue to be launched

Biotechnology Consulting Poland applies to the EU for structural and cohesion funding

Red Cross workers educate public on unfair labor conditions

RetireSafe calls for the Senate to oppose the Dorgan Importation plan

Findings underscore the need for additional medical student education for healthcare reform

Oxygen Biotherapeutics commences enrollment in clinical trial of Oxycyte emulsion for TBI

Biomagnetics Diagnostics discusses utilization of acquired Los Alamos National Security intellectual property

Study on fruit flies may help in understanding the root cause of stem cell diseases

Recession continues to impact low-income families with disabled children

Florida's top nonprofits receive awards for improving health care

Appropriate toys for children: Suggestions from doctors and experts

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News